Walter Wu
PEOPLE

Walter Wu

Partner
wu.walter@dorsey.com

Overview

WALTER HELPS EMERGING LIFE SCIENCE COMPANIES INTEGRATE THEIR PATENT PROSECUTION STRATEGY WITH THEIR BUSINESS STRATEGY, AND HELPS INVESTORS CRITICALLY ANALYZE THE PATENT STRATEGIES OF TARGET COMPANIES.

Dr. Wu specializes in patent prosecution and portfolio strategy for emerging companies in the life sciences, and patent due diligence for life science investors. His clients and target companies are active in the digital health, medical diagnostics, bioinformatics, ophthalmic, wound care and ENT fields. His transactional experience includes Alcon’s licensing of the Google Smart Lens technology and Auris Surgical Robotics’ acquisition of Hansen Medical. He has developed patent strategies for inter partes reviews and litigation matters involving surgical robots and prosthetic limbs, and is an expert on clinical, marketing and biostatistical issues relating to biotech and pharmaceutical patent litigation, including trial experience in Pfizer Inc. v. Ranbaxy Laboratories Ltd. involving Lipitor.

Walter received his medical degree from the UC Davis School of Medicine, where he was a UC Regents Scholar. During medical school, he completed policy fellowships at the National Governors' Association and the Food and Drug Administration. Walter is a licensed physician and was board-certified in internal medicine from 2000 to 2010. Before attending law school, he was a chief resident and clinical instructor at the UCLA School of Medicine.

Education & Admissions

University of California, Los Angeles (UCLA) (J.D., 2003)

University of California, Davis (M.D., 1996)

University of California, Los Angeles (UCLA) (B.S., 1991)

Admissions

  • California
  • United States Patent and Trademark Office

Languages

  • English

Experience

Representative Litigation

Patent prosecution and strategy work for:

  • Jenesis Surgical, acquired by Edwards Lifesciences Corp.
  • Spiracur Inc., acquired by KCI Licensing, Inc. 
  • Ciel Medical, Inc., acquired by Vyaire Medical, Inc.

Investor patent due diligence on:

  • Internet-connected glucometers and inhalers 
  • Accommodating intra-ocular lenses
  • Cloud-based genomics analysis
Patent litigation and Inter Partes Reviews involving:
  • surgical robotics
  • limb prosthetics

News & Resources

Select Presentations

  • Panelist, Berkeley - Stanford Advanced Patent Law Institute: Silicon Valley, “Section 112/Means Plus Function Claiming,” December 6, 2016
  • Speaker, Life Sciences Seminar Series, “Connections and Collaborations: High Tech + Life Sciences,” January 13, 2015
  • Speaker, Oxbridge Biotech Roundtable OneStart Biotech Boot Camp, February 8, 2014
  • Speaker, ITRI-Biodesign Alumni Association, “Medtech Ventures: Cross-Border Investment and Partnering Trends – Intellectual Property Development,” October 10, 2013
  • Moderator, SARTA, “The Future of Health & Medicine: Where Can Technology Take Us?,” May 14, 2013
  • Panelist, USC Gould School of Law’s Annual Institute for Corporate Counsel, “Intellectual Property and the In-House Lawyer: Current Issues and Strategies,” December 5, 2012
  • Speaker, ITRI, “Medical Devices: Current Trends, Patent Strategy & IP Due Diligence,” December 2, 2012
  • Moderator, Silicon Valley-China Wireless Technology Association, “Roll Out Your Mobile Apps for Health & Fitness,” May 8, 2012

Industries & Practices

Patent Prosecution, Portfolio Strategy & Management
  • Blockchain & Digital Assets
  • Dorsey Health Strategies
  • Emerging Companies
  • Energy & Natural Resources
  • Food, Beverage & Agribusiness
  • Healthcare
  • Intellectual Property Litigation
  • Patent Prosecution, Portfolio Strategy & Management
  • Products Liability
  • Technology

Professional & Civic

Community Involvement

  • Industry contributor/mentor, Stanford Biodesign 
    • Faculty Fellowship
    • Biodesign Innovation program
  • Volunteer team supervisor, UC Hastings StartUp Legal Garage
Walter Wu